Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study by Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks by Teppei Hagino, Risa Hamada, Mai Yoshida, Eita Fujimoto, Hidehisa Saeki, Naoko Kanda

Get full text

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Optimization and validation of a highly sensitive method for determining glyphosate in human urine by solid-phase extraction and liquid chromatography with tandem mass spectrometry... by Hiroshi Nomura, Risa Hamada, Isao Saito, Kunihiko Nakane, Ritsuko Sawa, Miwa Ukai, Eiji Shibata, Mitsuo Sato, Michihiro Kamijima, Jun Ueyama

Get full text

Simultaneous quantification of pyrethroid metabolites in urine of non-toilet-trained children in Japan by Jun Ueyama, Yuki Ito, Risa Hamada, Naoko Oya, Sayaka Kato, Taro Matsuki, Hazuki Tamada, Kayo Kaneko, Shinji Saitoh, Mayumi Sugiura-Ogasawara, Takeshi Ebara, Michihiro Kamijima

Get full text